採用

International Medical Director (IMD). GU/Hematology. JAPAC Region
Singapore Affiliate - Duo Tower
·
On-site
·
Full-time
·
1mo ago
Career Category
Medical Affairs
Job Description
Live
What you will do
Amgen is one of the world’s leading independent biotechnology companies. For over 4 decades, Amgen has pioneered biotechnology breakthroughs, to bring state-of-the-art medicines from laboratory to the patient. Amgen has not only discovered and developed innovative human therapeutics but has invested in cutting edge manufacturing capability and support services to deliver these exciting therapies to medical teams around the world. Japan and Asia Pacific (JAPAC) is the fastest growing region in Amgen. Now we are hiring an International Medical Director (IMD). GU/Hematology. JAPAC Region
Live
What you will do
Accountabilities:
Reporting to the Global Oncology Executive Medical Director, The JAPAC International Medical Director (IMD) is a Singapore-based medical affairs role leading JAPAC regional strategy and scientific engagement for the GU and Hematology portfolio focused on prostate cancer and acute lymphoblastic leukemia (ALL). The IMD partners with global medical leads and cross-functional teams to translate global strategy into JAPAC-relevant medical plans, supporting evidence generation, medical communications, and stakeholder engagement to inform registrational and lifecycle priorities.
Responsibilities:
- Global medical leadership: Represent JAPAC on the Global Medical Affairs Team to align regional strategy with global priorities.
- Regional medical strategy: Provide JAPAC treatment landscape insights to inform registrational support and lifecycle planning.
- Evidence generation: Lead/support regional evidence initiatives (e.g., investigator-sponsored research, RWE) to address key data gaps.
- Enable access to medicines through clear understanding and education of treatment value in partnership with cross-functional stakeholders
- Medical communications: Develop and execute the scientific narrative and deliverables (publications, congresses, medical education, core content).
- Safety & benefit–risk: Contribute to safety oversight and ensure consistent communication of benefit–risk considerations externally.
- Scientific partnerships: Strengthen Amgen’s scientific credibility through high-quality engagement with external stakeholders across JAPAC.
- Advisory boards: Design and run advisory boards to gather expert insights that shape medical strategy and evidence plans.
Win
What we expect from you
Basic Qualifications
Medical Degree: MD or DO (medical doctor) degree from an accredited medical school (or an equivalent doctoral degree such as a PhD or PharmD in a relevant field).
Relevant Experience: Minimum 5 years of oncology-focused Medical Affairs experience.
Regional leadership: Experience in leading GU/Heme medical strategies across multiple JAPAC country affiliates, aligning integrated plans across diverse markets, cross-functional stakeholders.
Preferred Qualifications
- Advanced clinical/scientific training: MD with relevant specialty training (board certified/eligible preferred); strong PhD or PharmD candidates considered based on overall profile.
- Substantial biopharma experience: ~10+ years in Medical Affairs (biotech/pharma/CRO), including pipeline support, launches, and/or mature brand lifecycle management.
- Therapeutic-area depth: Strong clinical/scientific expertise within the GU and Hematology therapeutic areas.
- External engagement: Demonstrated success partnering with KOLs, societies, patient groups, and payer/access stakeholders to advance medical objectives.
- Regulatory & compliance fluency: Working knowledge of major health authorities and guidelines; strong grounding in GCP and relevant medical affairs/clinical research regulations.
- Drug development & lifecycle acumen: Understanding of end-to-end development through approval and post-approval evidence/medical strategy.
- Analytical judgment: Strong problem-solving skills and sound medical/scientific judgment in complex, ambiguous situations.
- Scientific rigor: Ability to apply evidence-based thinking to strategy, communications, and stakeholder dialogue.
- Matrix leadership: Proven effectiveness leading through influence in cross-functional, matrixed environments.
Thrive
What you can expect from us
- As we work to develop treatments that take care of others, so we work to care for our teammates’ professional and personal growth and well-being Vast opportunities to learn and move up and across our global organization
- Diverse and inclusive community of belonging, where teammates are empowered to bring ideas to the table and act
- Generous Total Rewards Plan comprising health, finance and wealth, work/life balance, and career benefits
.
総閲覧数
0
応募クリック数
0
模擬応募者数
0
スクラップ
0
類似の求人

Asia Commercial Director – Singapore, India, and Korea
Medtronic · Singapore, Singapore, Singapore

Credit -Systematic Market Making – Vice President
JPMorgan Chase · Singapore, Singapore, SG

Lead Software Engineer
Cadence · NOIDA

Medical Science Liaison (1 year contract)
IQVIA · Singapore

Shift Supervisor
CVS Health · 2901 CLINT MOORE RD, Boca Raton, Florida,United States
Amgenについて

Amgen
PublicA biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
10,001+
従業員数
Thousand Oaks
本社所在地
$138B
企業価値
レビュー
3.6
24件のレビュー
ワークライフバランス
3.2
報酬
3.5
企業文化
3.1
キャリア
2.8
経営陣
3.4
65%
友人に勧める
良い点
Excellent benefits and health benefits
Good pay and compensation
Supportive management and leadership
改善点
Limited career growth and promotion opportunities
Work-life balance challenges and long hours
Bureaucratic processes
給与レンジ
1,002件のデータ
L2
L3
L4
L5
L6
L2 · Financial Analyst L2
0件のレポート
$94,068
年収総額
基本給
$37,627
ストック
$47,034
ボーナス
$9,407
$65,848
$122,288
面接体験
5件の面接
難易度
3.0
/ 5
期間
14-28週間
内定率
40%
体験
ポジティブ 20%
普通 80%
ネガティブ 0%
面接プロセス
1
Application Review
2
Recruiter Screen
3
Hiring Manager Interview
4
Technical/Case Interview
5
Final Round/Panel Interview
6
Offer
よくある質問
Technical Knowledge
Behavioral/STAR
Past Experience
Case Study
Culture Fit
ニュース&話題
FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
HN
·
6d ago
·
1
·
1
Amgen posts Q1 results April 30; anyone can hear the webcast live - Stock Titan
Stock Titan
News
·
1w ago
AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS - Yahoo Finance
Yahoo Finance
News
·
1w ago
Amgen’s Chief Technology Officer Dr David Reese to retire - European Pharmaceutical Review
European Pharmaceutical Review
News
·
1w ago